Edition:
United Kingdom

Viveve Medical Inc (VIVE.OQ)

VIVE.OQ on NASDAQ Stock Exchange Capital Market

5.10USD
15 Dec 2017
Change (% chg)

-- (--)
Prev Close
$5.10
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
42,055
52-wk High
$11.16
52-wk Low
$3.75

Chart for

About

Viveve Medical, Inc. designs, develops, manufactures and markets a medical device, Geneveve, for the non-invasive treatment of vaginal laxity, for improved sexual function, and for vaginal rejuvenation. The Company's, Geneveve, is a non-invasive solution for vaginal laxity, which includes three components: the Viveve System (a... (more)

Overall

Beta: -0.62
Market Cap(Mil.): $108.86
Shares Outstanding(Mil.): 19.41
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 168.71 16.44
EPS (TTM): -- -- --
ROI: -- 9.50 10.62
ROE: -- 14.87 14.20

BRIEF-Viveve Medical Inc files for mixed shelf of up to $50 million

* Viveve Medical Inc files for mixed shelf of up to $50 million Source text: (http://bit.ly/2zIf6EQ) Further company coverage:

08 Nov 2017

BRIEF-Viveve reports Q3 loss per share $0.50

* Q3 earnings per share view $-0.42 -- Thomson Reuters I/B/E/S

08 Nov 2017

BRIEF-Viveve releases preliminary Q3 2017 financial results

* Viveve releases preliminary third quarter 2017 financial results

18 Oct 2017

BRIEF-Viveve gets regulatory nod to market Viveve System in Mexico

* Viveve announces regulatory approval for Viveve System in Mexico

17 Oct 2017

BRIEF-Viveve announces regulatory approval for Viveve System in Taiwan

* Viveve announces regulatory approval for Viveve System in Taiwan

10 Oct 2017

BRIEF-Viveve announces additional regulatory approvals in Middle East

* Viveve announces additional regulatory approvals in Middle East

12 Sep 2017

BRIEF-Viveve Medical entered into a membership unit subscription agreement with ICM

* Viveve Medical Inc - in connection with distribution agreement, company also entered into a membership unit subscription agreement with ICM

10 Aug 2017

BRIEF-Viveve Medical reports Q2 loss per share $0.54

* Viveve announces second quarter 2017 financial results and strategic partnership with Incontrol Medical, Llc

10 Aug 2017

Earnings vs. Estimates